Results 71 to 80 of about 1,395 (139)

Juvenile Localized Scleroderma

, 2016
Francesco Zulian, Roberta Culpo
openaire   +1 more source

Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma. [PDF]

Br J Dermatol, 2019
Kurzinski KL, Zigler CK, Torok KS.
europepmc   +1 more source

CO:06:2 | Deep immunophenotyping in patients with juvenile localized scleroderma reveals two distinct immunological endophenotypes

Reumatismo
Background. The aim of this project is to perform immunophenotyping of patients with JLS and healthy controls to assess dysregulated immunological pathways in JLS, and to identify biomarkers able to predict clinical features.   Methods.
Società Italiana di Reumatologia
doaj  

Evaluation of autologous fat grafting in the treatment of juvenile localized scleroderma with facial involvement. [PDF]

J Scleroderma Relat Disord
Sander L, Foeldvari I, Glaser D, Klotsche J, Stier R, Roldán JC.   +5 more
europepmc   +1 more source

Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles. [PDF]

Semin Arthritis Rheum, 2015
Torok KS, Kurzinski K, Kelsey C, Yabes J, Magee K, Vallejo AN, Medsger T, Feghali-Bostwick CA.   +7 more
europepmc   +1 more source

Association of <i>MMP9</i> and <i>NOS3</i> Polymorphisms with Distinct Clinical Forms of Juvenile Scleroderma and Characteristics of Humoral Immunity. [PDF]

Int J Mol Sci
Osminina M, Podzolkova V, Litvinova M, Geppe N, Chebysheva S, Khachatryan L, Golovanova N, Kostina Y, Lazareva-Batyreva O, Polyanskaya A, Shpitonkova O, Subbotina T, Areian T, Podchernyaeva N.   +13 more
europepmc   +1 more source

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis [PDF]

Pediatr Rheumatol Online J, 2014
Culpo R, Vastert S, Ravelli A, Wulffraat N, Foeldvari I, Zulian F, Anton J, Avcin T, Baildam E, Boros C, Chaitow J, Constantin T, Dolezalova P, Kasapcopur O, de Oliveira S, Pilkington C, van Royen A, Russo R, Saad-Magalhaes C, Toplak N.   +19 more
europepmc   +1 more source

Clinical characteristics, autoantibody profiles, and therapeutic outcomes of juvenile systemic sclerosis: an 11-year single-center experience from China. [PDF]

Front Immunol
Wang Y, Tang W, Zhang Y, Zhang Z, An Y, Tang X.   +5 more
europepmc   +1 more source

Methotrexate in juvenile localized scleroderma: Adding to the evidence [PDF]

Arthritis & Rheumatism, 2011
openaire   +1 more source

Successful tocilizumab-based combination therapy for a case of rapidly progressive adult deep morphea with multiple antiphospholipid antibodies: a case report and literature review. [PDF]

Front Immunol
Yu R, Zhang L, Li SG, Zhang J, Li J, Zou Y, Long T, Zhang Y, Yue G.   +8 more
europepmc   +1 more source